Gut microbiome composition may be an indicator of preclinical Alzheimer's disease.
Ferreiro AL, Choi J, Ryou J, Newcomer EP, Thompson R, Bollinger RM, Hall-Moore C, Ndao IM, Sax L, Benzinger TLS, Stark SL, Holtzman DM, Fagan AM, Schindler SE, Cruchaga C, Butt OH, Morris JC, Tarr PI, Ances BM, Dantas G.
Ferreiro AL, et al.
Sci Transl Med. 2023 Jun 14;15(700):eabo2984. doi: 10.1126/scitranslmed.abo2984. Epub 2023 Jun 14.
Sci Transl Med. 2023.
PMID: 37315112
Free PMC article.
Alzheimer's disease (AD) pathology is thought to progress from normal cognition through preclinical disease and ultimately to symptomatic AD with cognitive impairment. ...The change in gut microbiome composition correlated with beta-amylo …
Alzheimer's disease (AD) pathology is thought to progress from normal cognition through preclinical disease and …